REQUEST A DEMO
Total
USD $0.00
Search more companies

Jimex Pharma De Alemania S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Forest Nurseries and Gathering of Forest Products | Pharmaceutical Preparation Manufacturing | Scientific Research and Development Services
Full name: Jimex Pharma De Alemania S.A.S. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Jimex Pharma De Alemania S.A.S. is a company based in Colombia, with its head office in Palmira. The enterprise operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on January 28, 2016. The total number of employees is currently 15 (2022). In 2021, the company reported a net sales revenue increase of 31.02%. Over the same period, its total assets grew by 4.72%. In 2021, Jimex Pharma De Alemania S.A.S.’s net profit margin increased by 6.2%.

Headquarters
Cr 16 A Cl 10 - 469 Vda La Torre
Palmira; Valle del Cauca;

Contact Details: Purchase the Jimex Pharma De Alemania S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Jimex Pharma De Alemania S.A.S. report to view the information.
Outstanding Shares:
Purchase the Jimex Pharma De Alemania S.A.S. report to view the information.
Incorporation Date:
January 28, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Jimex Pharma De Alemania S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.02%
Total operating revenue
31.02%
Operating profit (EBIT)
174.38%
Net Profit (Loss) for the Period
189.43%
Total assets
4.72%
Total equity
-61.03%
Operating Profit Margin (ROS)
9.06%
Net Profit Margin
6.2%
Return on Equity (ROE)
61.84%
Quick Ratio
-1.83%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?